in nine subjects who completed the trial , the clinical response , occurrence of dyskinesias and of nausea and vomiting , were similar with both treatments , although peak plasma levodopa concentration and levodopa bioavailability were greater on levodopa-domperidone than on levodopa-carbidopa .
C0023570
levodopa
C0353697
levodopa-carbidopa